Penetrance and Phenotype of the Cys433Arg Myocilin Mutation in a Family Pedigree with Primary Open-Angle Glaucoma
PURPOSETo evaluate the penetrance and the clinical characteristics of the Cys433Arg myocilin mutation in a family pedigree with primary open-angle glaucoma. PATIENTS AND METHODSPrimary open-angle glaucoma was defined as untreated intraocular pressure (IOP) over 24 mmHg, with characteristic optic ner...
Saved in:
Published in: | Journal of glaucoma Vol. 12; no. 2; pp. 104 - 107 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Lippincott Williams & Wilkins, Inc
01-04-2003
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | PURPOSETo evaluate the penetrance and the clinical characteristics of the Cys433Arg myocilin mutation in a family pedigree with primary open-angle glaucoma.
PATIENTS AND METHODSPrimary open-angle glaucoma was defined as untreated intraocular pressure (IOP) over 24 mmHg, with characteristic optic nerve and visual field glaucomatous damage. Patients with IOP <24 mm Hg who were currently being treated for primary open-angle glaucoma were included as affected individuals. Genomic DNA was collected from peripheral blood. PCR, single-strand conformation polymorphism, and sequencing analyses were performed to identify the presence of the Cys433Arg mutation in family members.
RESULTSOf the 48 members of this family evaluated, 17 (35%) were found to harbor the Cys433Arg mutation, 9 (53%) of whom were glaucomatous. None of the 31 individuals without the mutation had glaucoma. Among the 9 patients with glaucoma, 5 had undergone surgical procedure to improve IOP control, including all patients older than 40 years of age. The mutation's penetrance was 0% in persons younger than 10 years (0/4), 40% in those 11 to 30 years (2/5), 75% in persons 30 to 40 years (3/4), and 100% in those older than 40 years (4/4).
CONCLUSIONThe Cys433Arg mutation in this pedigree was associated with a phenotype characterized by early-onset open-angle glaucoma, which frequently requires surgical intervention and is associated with a high penetrance |
---|---|
AbstractList | PURPOSETo evaluate the penetrance and the clinical characteristics of the Cys433Arg myocilin mutation in a family pedigree with primary open-angle glaucoma.
PATIENTS AND METHODSPrimary open-angle glaucoma was defined as untreated intraocular pressure (IOP) over 24 mmHg, with characteristic optic nerve and visual field glaucomatous damage. Patients with IOP <24 mm Hg who were currently being treated for primary open-angle glaucoma were included as affected individuals. Genomic DNA was collected from peripheral blood. PCR, single-strand conformation polymorphism, and sequencing analyses were performed to identify the presence of the Cys433Arg mutation in family members.
RESULTSOf the 48 members of this family evaluated, 17 (35%) were found to harbor the Cys433Arg mutation, 9 (53%) of whom were glaucomatous. None of the 31 individuals without the mutation had glaucoma. Among the 9 patients with glaucoma, 5 had undergone surgical procedure to improve IOP control, including all patients older than 40 years of age. The mutation's penetrance was 0% in persons younger than 10 years (0/4), 40% in those 11 to 30 years (2/5), 75% in persons 30 to 40 years (3/4), and 100% in those older than 40 years (4/4).
CONCLUSIONThe Cys433Arg mutation in this pedigree was associated with a phenotype characterized by early-onset open-angle glaucoma, which frequently requires surgical intervention and is associated with a high penetrance To evaluate the penetrance and the clinical characteristics of the Cys433Arg myocilin mutation in a family pedigree with primary open-angle glaucoma. Primary open-angle glaucoma was defined as untreated intraocular pressure (IOP) over 24 mmHg, with characteristic optic nerve and visual field glaucomatous damage. Patients with IOP <24 mm Hg who were currently being treated for primary open-angle glaucoma were included as affected individuals. Genomic DNA was collected from peripheral blood. PCR, single-strand conformation polymorphism, and sequencing analyses were performed to identify the presence of the Cys433Arg mutation in family members. Of the 48 members of this family evaluated, 17 (35%) were found to harbor the Cys433Arg mutation, 9 (53%) of whom were glaucomatous. None of the 31 individuals without the mutation had glaucoma. Among the 9 patients with glaucoma, 5 had undergone surgical procedure to improve IOP control, including all patients older than 40 years of age. The mutation's penetrance was 0% in persons younger than 10 years (0/4), 40% in those 11 to 30 years (2/5), 75% in persons 30 to 40 years (3/4), and 100% in those older than 40 years (4/4). The Cys433Arg mutation in this pedigree was associated with a phenotype characterized by early-onset open-angle glaucoma, which frequently requires surgical intervention and is associated with a high penetrance PURPOSETo evaluate the penetrance and the clinical characteristics of the Cys433Arg myocilin mutation in a family pedigree with primary open-angle glaucoma. PATIENTS AND METHODSPrimary open-angle glaucoma was defined as untreated intraocular pressure (IOP) over 24 mmHg, with characteristic optic nerve and visual field glaucomatous damage. Patients with IOP <24 mm Hg who were currently being treated for primary open-angle glaucoma were included as affected individuals. Genomic DNA was collected from peripheral blood. PCR, single-strand conformation polymorphism, and sequencing analyses were performed to identify the presence of the Cys433Arg mutation in family members. RESULTSOf the 48 members of this family evaluated, 17 (35%) were found to harbor the Cys433Arg mutation, 9 (53%) of whom were glaucomatous. None of the 31 individuals without the mutation had glaucoma. Among the 9 patients with glaucoma, 5 had undergone surgical procedure to improve IOP control, including all patients older than 40 years of age. The mutation's penetrance was 0% in persons younger than 10 years (0/4), 40% in those 11 to 30 years (2/5), 75% in persons 30 to 40 years (3/4), and 100% in those older than 40 years (4/4). CONCLUSIONThe Cys433Arg mutation in this pedigree was associated with a phenotype characterized by early-onset open-angle glaucoma, which frequently requires surgical intervention and is associated with a high penetrance |
Author | Schimiti, Rui Costa, Vital Paulino de Vasconcellos, José Paulo Cabral Costa, Fernando Ferreira de Melo, Mônica Barbosa |
AuthorAffiliation | Departments of Ophthalmology and ‡Clinical Medicine - Hemocentro, University of Campinas, Campinas, †Department of Physiology, Santa Casa de São Paulo, and §Department of Ophthalmology, University of São Paulo, São Paulo, Brazil |
AuthorAffiliation_xml | – name: Departments of Ophthalmology and ‡Clinical Medicine - Hemocentro, University of Campinas, Campinas, †Department of Physiology, Santa Casa de São Paulo, and §Department of Ophthalmology, University of São Paulo, São Paulo, Brazil |
Author_xml | – sequence: 1 givenname: José Paulo surname: de Vasconcellos middlename: Cabral fullname: de Vasconcellos, José Paulo Cabral organization: Departments of Ophthalmology and ‡Clinical Medicine - Hemocentro, University of Campinas, Campinas, †Department of Physiology, Santa Casa de São Paulo, and §Department of Ophthalmology, University of São Paulo, São Paulo, Brazil – sequence: 2 givenname: Mônica surname: de Melo middlename: Barbosa fullname: de Melo, Mônica Barbosa – sequence: 3 givenname: Rui surname: Schimiti fullname: Schimiti, Rui – sequence: 4 givenname: Fernando surname: Costa middlename: Ferreira fullname: Costa, Fernando Ferreira – sequence: 5 givenname: Vital Paulino surname: Costa fullname: Costa, Vital Paulino |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/12671463$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kUtv1DAQxy1URB_wFZBP3ELH8SPZ42pFS6VW3QNI3CyvPdkEHHtrO1rl2xPYBU4cRjMj_ef1m2tyEWJAQiiDjwxWzS0AKMZWbVUDcBBLWi0G_BW5YpKrSrTs28USg2wqaOvVJbnO-TtADXXN3pBLVquGCcWvyMsWA5ZkgkVqgqPbHkMs8wFp7GjpkW7mLDhfpz19mqMd_BDo01RMGWKgS2zonRkHP9MtumGfEOlxKD3dpmE0aabPBwzVOuw90ntvJhtH85a87ozP-O7sb8jXu09fNp-rx-f7h836sbJcKl5JgbJDaICtXCdrBU61DiUXvDVWcOfMckwDUnbGwQ52yJTl7a5BxmwtWstvyIdT30OKLxPmoschW_TeBIxT1g1nqpZMLcL2JLQp5pyw04fT9pqB_oVb_8Gt_-LWv3Evpe_PM6bdiO5f4ZnvIhAnwTH6gin_8NMRk-7R-NLr_72R_wR3BYt7 |
CitedBy_id | crossref_primary_10_1080_13816810_2018_1546405 crossref_primary_10_1086_421533 crossref_primary_10_1371_journal_pone_0207409 crossref_primary_10_1080_13816810_2021_2021427 crossref_primary_10_1111_j_1463_5224_2008_00631_x crossref_primary_10_1016_j_exer_2005_11_002 crossref_primary_10_3390_molecules16075402 crossref_primary_10_1016_j_gene_2013_02_054 crossref_primary_10_1038_s41598_019_51281_y crossref_primary_10_1080_08820530701745199 |
Cites_doi | 10.1086/338709 10.1111/j.1749-6632.1998.tb10585.x 10.1093/oxfordjournals.aje.a113626 10.1056/NEJM199804093381503 10.1016/S0161-6420(01)00654-6 10.1021/bi00102a004 10.1086/340733 10.1006/geno.1997.4682 10.1038/1203 10.1093/hmg/8.5.899 10.1136/bjo.80.5.389 10.1074/jbc.273.11.6341 10.1073/pnas.90.10.4655 10.1016/S0161-6420(13)31615-7 10.1126/science.275.5300.668 10.1002/(SICI)1096-8628(19980413)76:5<438::AID-AJMG13>3.0.CO;2-N 10.1038/ng0593-47 10.1056/NEJM199304153281507 10.1177/002215540004801003 10.1017/S0016672300004584 10.1093/hmg/10.2.117 10.1016/S0002-9394(00)00536-5 10.1016/S0014-5793(97)00934-4 10.1093/hmg/6.10.1667 10.1074/mcp.M200023-MCP200 10.1136/jmg.37.4.301 |
ContentType | Journal Article |
Copyright | 2003 Lippincott Williams & Wilkins, Inc. |
Copyright_xml | – notice: 2003 Lippincott Williams & Wilkins, Inc. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1097/00061198-200304000-00003 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1536-481X |
EndPage | 107 |
ExternalDocumentID | 10_1097_00061198_200304000_00003 12671463 00061198-200304000-00003 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | - .Z2 0R 2V- 53G 5GY 5VS 8L- AAMTA AARTV AAYEP ABBUW ABOCM ABXRP ABXVJ ABZAD ACDDN ACEWG ACGFS ACWDW ACWRI ACXNZ ADFPA ADNKB AE3 AENEX AFUWQ AHULI AHVBC AJIOK AJNYG ALMA_UNASSIGNED_HOLDINGS AMJPA ASCII AWKKM BQLVK C45 CS3 DU5 DUNZO E.X EBS EJD EX3 F2K F2L F5P FL- H0 H0~ HZ IN IN~ JK3 JK8 K8S KD2 KMI L-C N9A N~M O9- OCUKA ODA OHASI OL1 OLG OLV OLW OLZ OPUJH ORVUJ OUVQU OVD OVDNE OXXIT P-K P2P R58 RIG RLZ RSW S4R S4S V2I WOQ WOW X3V X3W Z2 --- .-D 0R~ AAAAV AAHPQ AAIQE AASCR ABASU ABDIG ABJNI ABVCZ ACCJW ACGFO ACILI ACXJB ADGGA ADHPY AE6 AEETU AFDTB AGINI AHQNM AHRYX AINUH AJNWD AJZMW ALMTX AMKUR AMNEI AOHHW BS7 CGR CUY CVF DIWNM ECM EEVPB EIF FCALG GNXGY GQDEL HLJTE HZ~ IKREB IPNFZ NPM OJAPA TEORI TSPGW W3M YFH ZB8 ZFV ZZMQN AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c3563-54e5fe07019df5260d68de53438ac43dda2027055fad0b0be16c38b7e11c248c3 |
ISSN | 1057-0829 |
IngestDate | Fri Aug 16 04:37:51 EDT 2024 Fri Aug 23 03:40:08 EDT 2024 Sat Sep 28 07:46:52 EDT 2024 Thu Aug 13 19:45:28 EDT 2020 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c3563-54e5fe07019df5260d68de53438ac43dda2027055fad0b0be16c38b7e11c248c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 12671463 |
PQID | 73162516 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_73162516 crossref_primary_10_1097_00061198_200304000_00003 pubmed_primary_12671463 wolterskluwer_health_00061198-200304000-00003 |
ProviderPackageCode | L-C C45 AARTV ADFPA ASCII OLG ODA ABZAD ABBUW JK3 ADNKB JK8 H0~ OLV 8L- OLW OLZ F2K F2L OHASI AHVBC AJNYG FL- KMI K8S AJIOK OPUJH V2I S4R S4S DUNZO OVDNE AMJPA OVD AHULI ACEWG .Z2 AWKKM OUVQU ORVUJ X3V X3W ACDDN ACWRI ABXRP AAMTA E.X OCUKA ACXNZ OL1 ABXVJ IN~ KD2 OXXIT ACWDW |
PublicationCentury | 2000 |
PublicationDate | 2003-April 2003-Apr 2003-04-00 20030401 |
PublicationDateYYYYMMDD | 2003-04-01 |
PublicationDate_xml | – month: 04 year: 2003 text: 2003-April |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of glaucoma |
PublicationTitleAlternate | J Glaucoma |
PublicationYear | 2003 |
Publisher | Lippincott Williams & Wilkins, Inc |
Publisher_xml | – name: Lippincott Williams & Wilkins, Inc |
References | Rozsa (R18-3) 1998; 4 Vasconcellos (R17-3) 2000; 37 Stone (R7-3) 1999; 275 Copin (R25-3) 2002; 70 Kulkarni (R31-3) 2000; 76 Nguuen (R9-3) 1998; 273 Swiderski (R11-3) 2000; 41 Kubota (R8-3) 1997; 41 Karavanich (R29-3) 1998; 855 Karali (R10-3) 2000; 41 Sheffield (R6-3) 1993; 4 Synder (R26-3) 1991; 30 Leske (R3-3) 1983; 118 Vicent (R24-3) 2002; 70 Morissete (R23-3) 1998; 19 Alward (R14-3) 1998; 338 Br??zin (R22-3) 1998; 76 Fingert (R15-3) 1999; 8 Craig (R21-3) 2001; 108 Ueda (R13-3) 2000; 48 Green (R32-3) 2002; 1 Jacobson (R33-3) 2001; 10 Quigley (R4-3) 1993; 328 Shimizu (R19-3) 2000; 130 Mukhopadhyay (R30-3) 2002; 8 Ortego (R12-3) 1997; 413 Yokoe (R27-3) 1993; 90 Fautsch (R28-3) 2001; 42 Quigley (R1-3) 1996; 80 Johnson (R5-3) 1993; 100 Sarfarazi (R16-3) 1997; 6 Allingham (R20-3) 1998; 39 |
References_xml | – volume: 70 start-page: 448 year: 2002 ident: R24-3 publication-title: Am J Hum Genet doi: 10.1086/338709 contributor: fullname: Vicent – volume: 855 start-page: 294 year: 1998 ident: R29-3 publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.1998.tb10585.x contributor: fullname: Karavanich – volume: 118 start-page: 166 year: 1983 ident: R3-3 publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a113626 contributor: fullname: Leske – volume: 338 start-page: 1022 year: 1998 ident: R14-3 publication-title: N Engl J Med doi: 10.1056/NEJM199804093381503 contributor: fullname: Alward – volume: 108 start-page: 1607 year: 2001 ident: R21-3 publication-title: Ophthalmology doi: 10.1016/S0161-6420(01)00654-6 contributor: fullname: Craig – volume: 30 start-page: 9143 year: 1991 ident: R26-3 publication-title: Biochemistry doi: 10.1021/bi00102a004 contributor: fullname: Synder – volume: 8 start-page: 271 year: 2002 ident: R30-3 publication-title: Mol Vis contributor: fullname: Mukhopadhyay – volume: 39 start-page: 2288 year: 1998 ident: R20-3 publication-title: Invest Ophthalmol Vis Sci contributor: fullname: Allingham – volume: 70 start-page: 1575 year: 2002 ident: R25-3 publication-title: Am J Hum Genet doi: 10.1086/340733 contributor: fullname: Copin – volume: 41 start-page: 360 year: 1997 ident: R8-3 publication-title: Genomics doi: 10.1006/geno.1997.4682 contributor: fullname: Kubota – volume: 19 start-page: 319 year: 1998 ident: R23-3 publication-title: Nat Genet doi: 10.1038/1203 contributor: fullname: Morissete – volume: 8 start-page: 899 year: 1999 ident: R15-3 publication-title: Hum Mol Genet doi: 10.1093/hmg/8.5.899 contributor: fullname: Fingert – volume: 80 start-page: 389 year: 1996 ident: R1-3 publication-title: Br J Ophthalmol doi: 10.1136/bjo.80.5.389 contributor: fullname: Quigley – volume: 273 start-page: 6341 year: 1998 ident: R9-3 publication-title: J Biol Chem doi: 10.1074/jbc.273.11.6341 contributor: fullname: Nguuen – volume: 4 start-page: 20 year: 1998 ident: R18-3 publication-title: Mol Vis contributor: fullname: Rozsa – volume: 90 start-page: 4655 year: 1993 ident: R27-3 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.90.10.4655 contributor: fullname: Yokoe – volume: 100 start-page: 524 year: 1993 ident: R5-3 publication-title: Ophthalmology doi: 10.1016/S0161-6420(13)31615-7 contributor: fullname: Johnson – volume: 275 start-page: 668 year: 1999 ident: R7-3 publication-title: Science doi: 10.1126/science.275.5300.668 contributor: fullname: Stone – volume: 76 start-page: 438 year: 1998 ident: R22-3 publication-title: Am J Med Genet doi: 10.1002/(SICI)1096-8628(19980413)76:5<438::AID-AJMG13>3.0.CO;2-N contributor: fullname: Br??zin – volume: 4 start-page: 47 year: 1993 ident: R6-3 publication-title: Nat Genet doi: 10.1038/ng0593-47 contributor: fullname: Sheffield – volume: 328 start-page: 1097 year: 1993 ident: R4-3 publication-title: N Engl J Med doi: 10.1056/NEJM199304153281507 contributor: fullname: Quigley – volume: 48 start-page: 1321 year: 2000 ident: R13-3 publication-title: J Histochem Cytochem doi: 10.1177/002215540004801003 contributor: fullname: Ueda – volume: 76 start-page: 41 year: 2000 ident: R31-3 publication-title: Genet Res doi: 10.1017/S0016672300004584 contributor: fullname: Kulkarni – volume: 10 start-page: 117 year: 2001 ident: R33-3 publication-title: Hum Mol Genet doi: 10.1093/hmg/10.2.117 contributor: fullname: Jacobson – volume: 130 start-page: 165 year: 2000 ident: R19-3 publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(00)00536-5 contributor: fullname: Shimizu – volume: 413 start-page: 349 year: 1997 ident: R12-3 publication-title: Fed Eur Biochem Soc doi: 10.1016/S0014-5793(97)00934-4 contributor: fullname: Ortego – volume: 6 start-page: 1667 year: 1997 ident: R16-3 publication-title: Hum Mol Genet doi: 10.1093/hmg/6.10.1667 contributor: fullname: Sarfarazi – volume: 1 start-page: 394 year: 2002 ident: R32-3 publication-title: Mol Cell Proteomics doi: 10.1074/mcp.M200023-MCP200 contributor: fullname: Green – volume: 41 start-page: 729 year: 2000 ident: R10-3 publication-title: Invest Ophthalmol Vis Sci contributor: fullname: Karali – volume: 41 start-page: 3420 year: 2000 ident: R11-3 publication-title: Invest Ophthalmol Vis Sci contributor: fullname: Swiderski – volume: 37 start-page: 301 year: 2000 ident: R17-3 publication-title: J Med Genet doi: 10.1136/jmg.37.4.301 contributor: fullname: Vasconcellos – volume: 42 start-page: 2324 year: 2001 ident: R28-3 publication-title: Invest Ophthalmol Vis Sci contributor: fullname: Fautsch |
SSID | ssj0020221 |
Score | 1.7820207 |
Snippet | PURPOSETo evaluate the penetrance and the clinical characteristics of the Cys433Arg myocilin mutation in a family pedigree with primary open-angle glaucoma.... To evaluate the penetrance and the clinical characteristics of the Cys433Arg myocilin mutation in a family pedigree with primary open-angle glaucoma. Primary... |
SourceID | proquest crossref pubmed wolterskluwer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 104 |
SubjectTerms | Adolescent Adult Arginine - genetics Child Child, Preschool Cysteine - genetics Cytoskeletal Proteins DNA Mutational Analysis Eye Proteins - genetics Female Glaucoma, Open-Angle - diagnosis Glaucoma, Open-Angle - genetics Glaucoma, Open-Angle - surgery Glycoproteins - genetics Humans Intraocular Pressure Male Middle Aged Pedigree Penetrance Point Mutation Polymerase Chain Reaction Polymorphism, Single-Stranded Conformational |
Title | Penetrance and Phenotype of the Cys433Arg Myocilin Mutation in a Family Pedigree with Primary Open-Angle Glaucoma |
URI | http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00061198-200304000-00003 https://www.ncbi.nlm.nih.gov/pubmed/12671463 https://search.proquest.com/docview/73162516 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb5tAEF45jlS1qqq-6z730JuFBCxgcnRdR4lkp1XjVLmhfZFEdaCFoCr_vrMvHkqjtode0ArMgvk-Zmdnv2EQep_kTIKVo55e_48Im3l7KUm8IM1F6rPQl0KFsg-OZ0en6cdltByNXG3Bbt9_RRr2AdYqc_Yf0G47hR3QBsxhC6jD9q9w_wzG66pqEwGUhKvUcVYrBlhc1xEh8-psenkNwCgd-mVjJYfQpm3IA0Y1mItLE6n9bj9KoYptebQ428op-N0N_AF6i3s7OGyUsl9pzVWW5HZbutUHs06v9YnldEFh6r7tnbCWZmForX72IVJ5LHqBpKzbbo_5uUrR0pqEL81Fu6RSWrfYxslL1ajkRUUHYQ7SU8cYywyOpacSgQemO-xRNOzZYVvT2A7ptrDujdHCfIVYu3HBnqYRUTZNp9r7pBshnSrg6FO2f7JaZZvl6WYH7YZg26Ix2p0vDleH7SwfnCI9y3f3a-Vj9kuhv73S0Ce6MdG5h-7_LJV2ov6mUyd6DtDmIXpgocVzQ7lHaCSLx-jO2moznqAfHfMwPHHcMg-XOQbm4ZZ52DEPO-ZhaFNsmIcd87BiHrbMwx3zsKPWU3Syv9wsDjxb0MPjJE6UCEfGufRVBQCRxzCTFkkqZEwiklIeESGoCsX5cZxT4TOfySDhJGUzGQQ8jFJOnqFxURbyBcKqv5DxgCWcRYyHNMwF4QJODkiQSzFBgXukmb3RrKe30DBkLQyZhmGC3rlnn4GRVa8DLWTZ1Jkq7wYTgWSCnhtIuj7DZAbOBpzrDTDKTBpzdhvkL_94rVfobvcevEbjq6qRb9BOLZq3lnK_AIPorKs |
link.rule.ids | 315,782,786,27934,27935,64551,64571,65346,65366 |
linkProvider | Ovid |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1Lb9QwELZKKwFVVR6FslCoDyi3VEmceNNDDmEfXaC7WmkXQU-Wn4tElZTNhqr_vh4nW1pRDlw4xYfYSjxjz-ubGYTeUyO0veW47-L_MRFd_zgl1A9To9JARIFW4MoezbqTb2l_AGVy1lhVSD6rLo7g4a5pGEA7HLAL59mnmTcZfJ1lhdeb9bIzb5qfDJybGkASXj8rf5mVl08yJ5itNQ0sQIBLXfI01ATdogmh9iBs5cP-_MONZWYFmbPMrPLiQ7JpC_lpqzveu9ZdOfaHcrqNdi5LiHdXPxzc_ZbQGj75T7_7FO22Wi3OGzZ8hjZ08Rw9HLdx-z30c2qv1BX08NCYFwpPv-uiBO8vLg22KijuXVUxIflygcdXll2s7ovHdYMSwHbMcdOgA0NnkcVSawz-YzxtSmVgQMX4ebE41_jknNf2H_kL9GU4mPdGftvswZckoQDQ0InRAVSHVyaxVpaiqdIJiUnKZUyU4uCmCZLEcBWIQOiQSpKKrg5DGcWpJC_RZlEW-hXCsF4kZCioFLGQEY-MIlLZySEJjVYdFK5Jxy6aD2W3YvFuL9nNXjK3lx10uKYxswcQoiq80GVdMWj9ZZVE2kH7Del_rxnRrhVEdq5_hxdYk-LK_ka31__4_iF6NJqPT9npx8nnN-ixgxs6bNEB2lwta_0WPahU_a5l-mt27gSp |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV3Lb9MwGLegkybQxHNsZcB8QLkFJXHihkMOUdpuhTWK1CHgZPmVIjElW9OA-t_jz0n3EHDgwik-xFZs_-Lv9fP3IfSWlkKbU467Nv4fEjFy38eEun5cqtgTgacVuLJPF6P8SzyeQJqcbQQfLp81l-_gYY9paEA5HLALz5MPCydbZMlXJ598XiS5U6QnE-umBpKEU4ynycYZJ_WPcu2keWLFs7GpAQgEsGqvUENm0B0aGkVhgHbSbHY2u7bPjDiz9plRYVy4ctoTf_ocj38c6640-01FfYj2ftYQ9W6-W9L7LdE1ffxfJ_0EPeo1XJx2kHyK7unqGdqd9zH85-iqMMfrGup5aMwrhYtvuqrBE4zrEht1FGebJiQkXS3xfGOgY_RgPG87xgA2bY67Yh0YqowsV1pj8CXjokubgYEh46bV8kLjkwvempnyffRpOjnPTt2-8IMrSUSBrKGjUnuQKV6VkbG4FI2VjkhIYi5DohQHl40XRSVXnvCE9qkksRhp35dBGEvyAg2qutKHCMN4gZC-oFKEQgY8KBWRynT2iV9qNUT-dgPZZfeh7FZc3q4lu15LZtdyiI63O83MzwgRFl7pum0YlAEzCiMdooMOADdjBnRkhJLp695BBOuuu7K_7dvLf3z_GO0aSLCzWf7xCD2wzENLM3qFButVq1-j-41q3_TI_wUn3QeC |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Penetrance+and+phenotype+of+the+Cys433Arg+myocilin+mutation+in+a+family+pedigree+with+primary+open-angle+glaucoma&rft.jtitle=Journal+of+glaucoma&rft.au=de+Vasconcellos%2C+Jos%C3%A9+Paulo+Cabral&rft.au=de+Melo%2C+M%C3%B4nica+Barbosa&rft.au=Schimiti%2C+Rui&rft.au=Costa%2C+Fernando+Ferreira&rft.date=2003-04-01&rft.issn=1057-0829&rft.volume=12&rft.issue=2&rft.spage=104&rft.epage=107&rft_id=info:doi/10.1097%2F00061198-200304000-00003&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1057-0829&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1057-0829&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1057-0829&client=summon |